## Abstract Endothelium‐derived relaxation mediated primarily by endothelium‐derived relaxing factor/nitric oxide (EDRF/NO) is essential in the maintenance of vascular tone. However, little is known about the effects of denervation on EDRF‐mediated relaxation in the microcirculation after reimplant
Preservation of the vasodilative effect of endothelium-derived relaxing factor in the hind limb of the rat
✍ Scribed by Dr. Hiroshi Ono; Yoji Nakagawa; Susumu Tamai; Shigeru Mizumoto
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 564 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0738-1085
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Using an extracorporeal circulatory system of fresh blood, the vasodilative effect of endothelium‐derived relaxing factor (EDRF) secreted from vascular endothelium, stimulated by acetylcholine (ACh), was evaluated. The bioassay cascade technique was applied to elucidate the release of EDRF. Elevated blood pressure of freshly amputated rat hind limbs, created by injection of norepinephrine (NE), decreased by 56% with ACh infusion, suggesting the existence of EDRF in the peripheral vascular system of rat hind limbs. The vasodilative effect of EDRF could be preserved for at least 6 hours when stored at room temperature. The effect of EDRF decreased markedly following storage for more than 9 hours at room temperature and storage for more than 3 hours at 4°C. © 1994 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract To determine whether endothelium‐derived relaxing factor (EDRF) contributes to the regulation of endothelial permeability, the transendothelial flux of ^14^C‐su‐crose, a marker for the paracellular pathway across endothelial monolayers (Oliver, __J. Cell. Physiol.__ 145:536–548, 1990),
Arecae semen extract relaxed aortic ring preparations of isolated rat aorta that contained endothelium from 3ϫ 10 Ϫ 7 g/mL, reaching a maximum of 86% at 10 Ϫ 5 g/mL. Its relaxation did not occur in specimens without endothelium, and was inhibited by pretreatment with 10 Ϫ 4 M N G -nitro-1-arginine m